Atenolol 25 mg clinical studies
Pro Research Analysisby 
Searched over 200M research papers
Atenolol 25 mg: Clinical Efficacy in Hypertension
Several clinical studies have evaluated the effectiveness of atenolol 25 mg in managing hypertension. Research comparing different doses of atenolol (25, 50, 75, and 100 mg) found that the reduction in blood pressure achieved with 25 mg daily was not significantly different from that seen with 100 mg, suggesting that the antihypertensive effect plateaus at lower doses for many patients Marshall1979Marshall2008. However, the degree of cardiac beta-blockade, as measured by suppression of exercise-induced tachycardia, was not maximal at 25 mg, indicating that while blood pressure control may be adequate, full beta-blockade may require higher doses Marshall1979Marshall2008. Other studies also observed a relatively flat relationship between plasma atenolol concentration and antihypertensive response, further supporting the effectiveness of lower doses for blood pressure reduction in mild-to-moderate hypertension .
Atenolol 25 mg in Combination Therapies
Clinical trials have shown that combining atenolol 25 mg with other antihypertensive agents can enhance blood pressure control. For example, a study comparing atenolol 25 mg/amlodipine 2.5 mg combination therapy to atenolol 25 mg monotherapy found that the combination was superior in reducing both systolic and diastolic blood pressure, with a higher response rate and more patients achieving target blood pressure levels . Similarly, combining atenolol 25 mg with chlorthalidone 6.25 mg was found to be as effective as higher-dose atenolol monotherapy or atenolol/amlodipine combinations, with no significant differences in blood pressure reduction or responder rates, and with a favorable safety profile . These findings suggest that low-dose combination therapy can be an effective and safe strategy for patients not adequately controlled on monotherapy.
Atenolol 25 mg: Effects on Intraocular Pressure and Blood Flow
Atenolol 25 mg has also been studied for its effects beyond blood pressure control. In patients with raised intraocular pressure (IOP), atenolol 25 mg produced a reduction in IOP, though the effect was dose-dependent and more pronounced with higher doses . In hypertensive patients, atenolol 25 mg led to a significant decrease in IOP and ophthalmic artery blood flow velocity, with a greater effect than amlodipine 5 mg . These results indicate that atenolol 25 mg may have additional benefits in patients with coexisting hypertension and ocular hypertension.
Pharmacokinetics and Bioequivalence of Atenolol 25 mg
Pharmacokinetic studies in healthy volunteers and elderly patients have shown that atenolol 25 mg tablets, including orally disintegrating formulations, have similar absorption and elimination profiles to conventional tablets, meeting bioequivalence criteria Li2024Khalid2023. The maximum plasma concentration (Cmax) for atenolol 25 mg is typically reached around 4 hours post-dose, and the elimination half-life is approximately 5 hours . These findings support the use of atenolol 25 mg in various patient populations, including those who may have difficulty swallowing traditional tablets.
Safety and Tolerability of Atenolol 25 mg
Across multiple studies, atenolol 25 mg was generally well tolerated, with most adverse events being mild and no serious adverse events reported Li2024Pareek2008. The safety profile of atenolol 25 mg, both as monotherapy and in combination with other antihypertensive agents, supports its use as a first-line or adjunctive therapy in the management of hypertension.
Conclusion
Atenolol 25 mg is effective in lowering blood pressure in patients with mild-to-moderate hypertension, with efficacy comparable to higher doses for many individuals Ishizakii1983Marshall1979Marshall2008. Its use in combination with other antihypertensive agents can further improve blood pressure control and is well tolerated Pareek2010Pareek2008. Additionally, atenolol 25 mg may offer benefits in reducing intraocular pressure and is available in bioequivalent formulations suitable for different patient needs Li2024Stenkula1982Behera2021+1 MORE. Overall, atenolol 25 mg is a versatile and effective option in the clinical management of hypertension.
Sources and full results
Most relevant research papers on this topic